Oxford Asset Management’s Neos Therapeutics, Inc NEOS Stock Holding History

Oxford Asset Management’s Portfolio NEOS Stock Details NEOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-90,202	Closed	-$136K	–	1637
2019 Q4	$136K	Sell	90,202 -64,860	-42%	-$97.3K	﹤0.01%	1598
2019 Q3	$229K	Buy	155,062 +50,221	+48%	+$81.3K	0.01%	1543
2019 Q2	$135K	Buy	104,841 +59,135	+129%	+$109K	﹤0.01%	1594
2019 Q1	$119K	Buy	45,706 +21,535	+89%	+$50.5K	﹤0.01%	1559
2018 Q4	$40K	Buy	+24,171	New	+$67.8K	﹤0.01%	1716
2018 Q1	–	Sell	-395,103	Closed	-$3.93M	–	1993
2017 Q4	$3.93M	Buy	+395,103	New	+$3.79M	0.08%	288

Other funds holding NEOS

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Oxford Asset Management's NEOS Position: Q1 2020 in Review

Oxford Asset Management sold out of Neos Therapeutics, Inc (NEOS) in Q1 2020, closing a stake of 90,202 shares — an estimated $136K sold.

Oxford Asset Management first reported a position in NEOS in Q4 2017 and held it in 6 quarters. The position peaked at $3.93M in Q4 2017. 49 funds tracked by Wall St. Rank hold NEOS as of Q1 2020.

Oxford Asset Management reported no remaining Neos Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Oxford Asset Management sold 90,202 Neos Therapeutics, Inc shares in Q1 2020, an estimated $136K.
Oxford Asset Management first reported a position in Neos Therapeutics, Inc in Q4 2017 and held it in 6 quarters.
Oxford Asset Management's Neos Therapeutics, Inc position peaked at $3.93M in Q4 2017.
49 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.